78 related articles for article (PubMed ID: 21625079)
21. Association between genetic variants in glutathione peroxidase 1 gene and risk of prostate cancer: a meta-analysis.
Liwei L; Wei Z; Ruifa H; Chunyu L
Mol Biol Rep; 2012 Sep; 39(9):8615-9. PubMed ID: 22699881
[TBL] [Abstract][Full Text] [Related]
22. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis.
Ntais C; Polycarpou A; Ioannidis JP
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):176-81. PubMed ID: 15668493
[TBL] [Abstract][Full Text] [Related]
23. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer.
Zhang HT; Xu Y; Zhang ZH; Li L
Genet Mol Res; 2012 Jun; 11(2):1642-50. PubMed ID: 22782583
[TBL] [Abstract][Full Text] [Related]
25. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
[TBL] [Abstract][Full Text] [Related]
26. Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis.
Fang S; Wang L; Jia C
Thromb Res; 2010 May; 125(5):e197-201. PubMed ID: 20100625
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
28. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
Fukatsu T; Hirokawa Y; Araki T; Hioki T; Murata T; Suzuki H; Ichikawa T; Tsukino H; Qiu D; Katoh T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
Anticancer Res; 2004; 24(4):2431-7. PubMed ID: 15330195
[TBL] [Abstract][Full Text] [Related]
30. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
31. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies.
Wei BB; Xi B; Wang R; Bai JM; Chang JK; Zhang YY; Yoneda R; Su JT; Hua LX
Cancer Genet Cytogenet; 2010 Jan; 196(1):68-75. PubMed ID: 19963138
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis: a meta-analysis.
Wang X; Xiao H; Lan H; Mao C; Chen Q
Respirology; 2011 Jul; 16(5):790-5. PubMed ID: 21470339
[TBL] [Abstract][Full Text] [Related]
33. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
34. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
Huang SP; Wu WJ; Chang WS; Wu MT; Chen YY; Chen YJ; Yu CC; Wu TT; Lee YH; Huang JK; Huang CH
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2217-24. PubMed ID: 15598783
[TBL] [Abstract][Full Text] [Related]
35. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M; Ansari-Lari M
Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
[TBL] [Abstract][Full Text] [Related]
36. Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.
Costa S; Pinto D; Morais A; Vasconcelos A; Oliveira J; Lopes C; Medeiros R
Prostate; 2005 Aug; 64(3):246-52. PubMed ID: 15717312
[TBL] [Abstract][Full Text] [Related]
37. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
Wang J; Yu W; Cai Y; Ren C; Ittmann MM
Neoplasia; 2008 Aug; 10(8):847-56. PubMed ID: 18670643
[TBL] [Abstract][Full Text] [Related]
38. Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.
Ntais C; Polycarpou A; Ioannidis JP
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):120-6. PubMed ID: 12582021
[TBL] [Abstract][Full Text] [Related]
39. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
[TBL] [Abstract][Full Text] [Related]
40. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
